263 related articles for article (PubMed ID: 27510628)
1. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
2. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
4. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
[TBL] [Abstract][Full Text] [Related]
5. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
7. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
10. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
[TBL] [Abstract][Full Text] [Related]
11. Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation.
Boninsegna E; Negrelli R; Zamboni GA; Tedesco G; Manfredi R; Pozzi Mucelli R
Eur J Radiol; 2017 Oct; 95():236-241. PubMed ID: 28987673
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
[TBL] [Abstract][Full Text] [Related]
13. Pancreatitis and PDAC: association and differentiation.
Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
[TBL] [Abstract][Full Text] [Related]
14. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.
Kersting S; Konopke R; Kersting F; Volk A; Distler M; Bergert H; Saeger HD; Grützmann R; Bunk A
Gastroenterology; 2009 Dec; 137(6):1903-11. PubMed ID: 19715694
[TBL] [Abstract][Full Text] [Related]
15. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.
Gong XH; Xu JR; Qian LJ
Abdom Radiol (NY); 2021 Sep; 46(9):4226-4237. PubMed ID: 33914139
[TBL] [Abstract][Full Text] [Related]
16. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
[TBL] [Abstract][Full Text] [Related]
17. Multiphase evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic solid lesions.
Ishikawa T; Hirooka Y; Kawashima H; Ohno E; Hashizume K; Funasaka K; Nakamura M; Miyahara R; Watanabe O; Ishigami M; Goto H
Pancreatology; 2018 Apr; 18(3):291-297. PubMed ID: 29449151
[TBL] [Abstract][Full Text] [Related]
18. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
Liu K; Xie P; Peng W; Zhou Z
J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of pancreatic head ductal adenocarcinoma from inflammatory pancreatic pseudomass by MR cholangio-pancreatography: utility of the duct-interrupted, corona, and attraction signs.
Beker K; Lee KS; Tsai LL; Hegazi T; Garces-Descovich A; Brook A; Mortele KJ
Abdom Radiol (NY); 2019 Dec; 44(12):4048-4056. PubMed ID: 31352623
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
